Treatment-Emergent Antibodies to Amustaline/Glutathione Pathogen-Reduced Red Blood Cells in the ReCePI Phase III Clinical Trial

被引：0
|
作者：
Panigrahi, A. [1 ]
Pearl, R. [1 ]
Pelletier, J. [2 ]
Sodha, N. [3 ]
Reece, T. [4 ]
Nuttall, G. [5 ]
Karim, C. [6 ]
Erickson, A. [6 ]
Mufti, N. [6 ]
Benjamin, R. [6 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[2] Univ Florida, Gainesville, FL USA
[3] Rhode Isl Hosp, Providence, RI USA
[4] Univ Colorado Hosp, Denver, CO USA
[5] Mayo Clin, Rochester, MN USA
[6] Cerus Corp, Concord, CA USA
来源：
TRANSFUSION | 2024年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OA4-AM24-M
引用
收藏
页码：51A / 52A
页数：2
相关论文
共 40 条
  • [1] Manufacturing Amustaline/Glutathione Pathogen-Reduced Red Cells to Support the ReCePI Phase III Clinical Study
    Sadler, P.
    Reik, R.
    Marschner, S.
    Brown, B.
    Prichard, A.
    Gammon, R.
    Hedrick, T.
    Waldhaus, K.
    Erickson, A.
    Benjamin, R.
    TRANSFUSION, 2024, 64 : 117A - 118A
  • [2] Transfusion Efficacy and Safety of Amustaline/Glutathione Pathogen-Reduced Red Blood Cells: Results of a Randomized, Controlled Phase III Trial
    Benjamin, Richard J.
    Snyder, Edward L.
    Sekela, Michael
    Welsby, Ian
    Toyoda, Yoshiya
    Alsammak, Mohamed
    Sodha, Neel
    Beaver, Thomas
    Pelletier, J. Peter
    Gorham, James
    Mcneil, John
    Sniecinski, Roman
    Pearl, Ronald
    Nuttall, Gregory A.
    Sarode, Ravi
    Reece, T. Brett
    Kaplan, Alesia
    Davenport, Robertson
    Ipe, Tina
    Benharash, Peyman
    Lopez-Plaza, Ileana
    Sadler, Patrick
    Reik, Rita
    Gammon, Richard
    Corash, Laurence
    Liu, Kathy
    Mufti, Nina
    Varrone, Jeanne T.
    BLOOD, 2024, 144 : 5592 - 5593
  • [3] Acute Kidney Injury to Evaluate Amustaline/Glutathione Pathogen Reduced Red Cells in Cardiac Surgery: Outcomes of the ReCePI Phase III Clinical Trial
    Sekela, M.
    Snyder, E.
    Welsby, I.
    Toyoda, Y.
    Sodha, N.
    Beaver, T.
    Liu, K.
    Corash, L.
    Mufti, N.
    Benjamin, R.
    TRANSFUSION, 2024, 64 : 9A - 9A
  • [4] Characterizing the antibody response to amustaline/glutathione pathogen-reduced red blood cells
    Karim, Christopher
    Panigrahi, Anil
    Pearl, Ronald G.
    Sodha, Neel R.
    Beaver, Thomas M.
    Pelletier, J. Peter R.
    Nuttall, Gregory A.
    Reece, T. Brett
    Erickson, Anna
    Hedrick, Teresa
    Liu, Kathy
    Bentow, Stanley
    Corash, Laurence
    Mufti, Nina
    Varrone, Jeanne
    Benjamin, Richard J.
    TRANSFUSION, 2025, 65 (02) : 344 - 353
  • [5] HLA Alloimmunization in ReCePI, a Phase III Study of Amustaline/Glutathione Pathogen Reduced RBCs
    Norris, P.
    Stone, M.
    Di Germanio, C.
    Balasko, B.
    Kaidarova, Z.
    Friend, H.
    Liu, K.
    Corash, L.
    Mufti, N.
    Benjamin, R.
    TRANSFUSION, 2024, 64 : 49A - 49A
  • [6] Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells
    Geisen, Christof
    North, Anne
    Becker, Lisa
    Brixner, Veronika
    von Goetz, Melissa
    Corash, Laurence
    Benjamin, Richard J.
    Mufti, Nina
    Seifried, Erhard
    TRANSFUSION, 2020, 60 (10) : 2389 - 2398
  • [7] Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study—protocol for a phase 3, randomized, controlled trial
    Edward L. Snyder
    Michael E. Sekela
    Ian J. Welsby
    Yoshiya Toyoda
    Mohamed Alsammak
    Neel R. Sodha
    Thomas M. Beaver
    J. Peter R. Pelletier
    James D. Gorham
    John S. McNeil
    Roman M. Sniecinski
    Ronald G. Pearl
    Gregory A. Nuttall
    Ravi Sarode
    T. Brett Reece
    Alesia Kaplan
    Robertson D. Davenport
    Tina S. Ipe
    Peyman Benharash
    Ileana Lopez-Plaza
    Richard R. Gammon
    Patrick Sadler
    John P. Pitman
    Kathy Liu
    Stanley Bentow
    Laurence Corash
    Nina Mufti
    Jeanne Varrone
    Richard J. Benjamin
    Trials, 24
  • [8] Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial
    Snyder, Edward L.
    Sekela, Michael E.
    Welsby, Ian J.
    Toyoda, Yoshiya
    Alsammak, Mohamed
    Sodha, Neel R.
    Beaver, Thomas M.
    Pelletier, J. Peter R.
    Gorham, James D.
    McNeil, John S.
    Sniecinski, Roman M.
    Pearl, Ronald G.
    Nuttall, Gregory A.
    Sarode, Ravi
    Reece, T. Brett
    Kaplan, Alesia
    Davenport, Robertson D.
    Ipe, Tina S.
    Benharash, Peyman
    Lopez-Plaza, Ileana
    Gammon, Richard R.
    Sadler, Patrick
    Pitman, John P.
    Liu, Kathy
    Bentow, Stanley
    Corash, Laurence
    Mufti, Nina
    Varrone, Jeanne
    Benjamin, Richard J.
    TRIALS, 2023, 24 (01)
  • [9] Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia
    Aydinok, Yesim
    Piga, Antonio
    Origa, Raffaella
    Mufti, Nina
    Erickson, Anna
    North, Anne
    Waldhaus, Katie
    Ernst, Christine
    Lin, Jin-Sying
    Huang, Norman
    Benjamin, Richard J.
    Corash, Laurence
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (04) : 625 - 636
  • [10] Human leukocyte antigen alloimmunization in a randomized trial of amustaline/glutathione pathogen-reduced red cells in complex cardiac surgery patients
    Norris, Philip J.
    Stone, Mars
    Di Germanio, Clara
    Balasko, Brendan
    Kaidarova, Zhanna
    Friend, Henry
    Varrone, Jeanne
    Corash, Laurence
    Mufti, Nina
    Benjamin, Richard J.
    TRANSFUSION, 2025,
1234